chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Abasia, Fall, Feeling abnormal, Injection site pain, Injection site warmth
Clinical narrative: Arm, legs, head, (fell body) tremors, unable to walk, stand, woke after a nap (2 hours) went to get up and fell to the floor "Brain felt mussy" 11/10/11 felt much better tremors gone 11/11/11 no tremors (LO) - warm, sore.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Tremor
Clinical narrative: Arm, legs, head, (fell body) tremors, unable to walk, stand, woke after a nap (2 hours) went to get up and fell to the floor "Brain felt mussy" 11/10/11 felt much better tremors gone 11/11/11 no tremors (LO) - warm, sore.
Age: 66.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Immobile, Inflammation
Clinical narrative: Patient reports inflammation and immobility. States could not work today & went to doctor. Prescribed MEDROL dose pack and instructed to immobilize arm & alt. heat/cold. Right arm/PNEUMOVAX.
Age: 72.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: 6"-8" red, raised, warm area 2 days post vaccine. No complaints of fever or pain or discharge. Area involved is where PNEUMOVAX was given.
Age: 13.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Agitation, Dizziness, Fatigue, Tremor, Vertigo
Clinical narrative: Fatigue, dizziness, tremors, blurred vision, felt like room spinning, feeling "hyped". Tx: close observation, reassurance.
Age: 13.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Vision blurred
Clinical narrative: Fatigue, dizziness, tremors, blurred vision, felt like room spinning, feeling "hyped". Tx: close observation, reassurance.
Age: 44.0
Sex: F
Vaccine: TDAP
Symptoms: Abdominal pain upper, Anxiety, Diarrhoea, Fatigue, Headache
Clinical narrative: 11/3 am - fatigue (extreme). 11/3 1pm - stomach ache (diarrhea x 3 hour) stomach pain lasted 3 d. 2 pm - body ache, muscle pain (severe), anxiety, migraine. 11/4 6 am - vomit, migraine HA from 2 pm 11/3 -> 2 pm 11/4 (24 hours) body aches, muscle pain continues through 11/8.
Age: 44.0
Sex: F
Vaccine: TDAP
Symptoms: Migraine, Myalgia, Pain, Vomiting
Clinical narrative: 11/3 am - fatigue (extreme). 11/3 1pm - stomach ache (diarrhea x 3 hour) stomach pain lasted 3 d. 2 pm - body ache, muscle pain (severe), anxiety, migraine. 11/4 6 am - vomit, migraine HA from 2 pm 11/3 -> 2 pm 11/4 (24 hours) body aches, muscle pain continues through 11/8.
Age: 75.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: - Red, warm at injection site - no itching on (R) arm, - About 6 inches in diameter, - Recommended ice pack to patient to relieve redness.
Age: 12.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Erythema, Oedema peripheral, Pyrexia
Clinical narrative: Mom called, stated patient developed a swollen and reddened arm (right). She stated he received a vaccine on 11-9-11 & developed a 103 degrees fever & the symptoms on 11-10-11.
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Oedema peripheral, Pain
Clinical narrative: Swelling in the lower arm. Patient reports pain and dizziness.
Age: 36.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Electrocardiogram normal, Injection site erythema, Myalgia, Pain, Vaccination site swelling
Clinical narrative: Patient developed heat, swelling, redness to vaccination site w/in 24 hours. C/o muscle pain with palp/movement (R) shoulder/chest wall.
Age: 36.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Vaccination site warmth
Clinical narrative: Patient developed heat, swelling, redness to vaccination site w/in 24 hours. C/o muscle pain with palp/movement (R) shoulder/chest wall.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Inflammation, Malaise, Reaction to preservatives
Clinical narrative: Allergic type reaction that the patient has experienced in the past with certain preservatives. The reaction patient describes as inflammation in her neck and general malaise. Started evening of vaccine.
Age: 92.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Feeling cold, Tremor
Clinical narrative: After receiving vaccine, patient went out to dinner & started to feel cold. She felt extremely cold thru the night & was shaky. In morning she felt very tired. Lack of sleep (??).
Age: 11.0
Sex: M
Vaccine: FLU3
Symptoms: Rash erythematous
Clinical narrative: Pt given vaccine. Within 5 minutes pt developed red none raised rash with 3 x 2 inch. No other signs. Ice pack applied to area. Rash diminishing after 15 minutes. Mother instructed on aftercare and follow-up.
Age: 40.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Chest discomfort, Flushing, Headache, Lip oedema, Myalgia
Clinical narrative: Symptoms occurred several hours after receiving the flu vaccine. Symptoms included low-grade fever, facial flushing, headache, edema of lower lip and hands, chest tightness, and myalgia. Symptoms improved with administration of BENADRYL.
Age: 40.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Oedema peripheral, Pyrexia
Clinical narrative: Symptoms occurred several hours after receiving the flu vaccine. Symptoms included low-grade fever, facial flushing, headache, edema of lower lip and hands, chest tightness, and myalgia. Symptoms improved with administration of BENADRYL.
Age: 58.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Erythema, Injection site erythema, Injection site swelling, Injection site warmth, Oedema peripheral
Clinical narrative: Swollen (L) arm with redness from upper (L) arm to (L) hand - warm & reddened. 11/11/11 - given ANCEF 1gm IM/KENALOG 80 mg IM fat.
Age: 58.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Skin warm
Clinical narrative: Swollen (L) arm with redness from upper (L) arm to (L) hand - warm & reddened. 11/11/11 - given ANCEF 1gm IM/KENALOG 80 mg IM fat.
Age: 74.0
Sex: F
Vaccine: UNK
Symptoms: Chills, Fatigue, Pain
Clinical narrative: Tired - body aches - chills - lasted 4 days.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Diarrhoea, Fatigue, Nausea, Vomiting
Clinical narrative: Nausea, vomiting, diarrhea, chills, fatigue.
Age: 48.0
Sex: F
Vaccine: UNK
Symptoms: Abdominal discomfort, Chills, Headache, Pain, Vomiting
Clinical narrative: Vomiting. Headache. Body aches. Chills. Stomach upset. Last for 5 days.
Age: 38.0
Sex: F
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: Got the flu.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Pt came in 2 days following a DTaP received in (L) thigh. 8 x 10 cm area of redness, very tender & warm.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Bursitis, Injected limb mobility decreased
Clinical narrative: Day after flu vaccine administration in (L) deltoid, pt developed pain in (L) shoulder joint & decreased ROM, consistent with bursitis. Sx persisted for 2 wks before she came in for evaluation. Ortho MD eval already scheduled day after our ofc eval.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Pt received ZOSTAVAX vaccine and developed red round spot that subsided after 7 days. Pt had had reaction to Tetanus vaccine.
Age: 29.0
Sex: F
Vaccine: FLU3
Symptoms: Cold sweat, Disorientation, Dizziness, Feeling abnormal, Loss of consciousness
Clinical narrative: Within minute of shot patient complained of lightheaded. Approx 2 min after shot patient passed out for about a minute then regained consciousness. Felt horrible & still was disoriented. Patient skin got clammy. Squad was called & pt transported to hospital.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Injection site warmth, Rash erythematous
Clinical narrative: A red raised rash developed at the site of injection on the 3 third day of administration rash grew to twice the size of quarter and was not to touch. Pt went to the MD who sent her to ER.
Age: 20.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site rash
Clinical narrative: Member recieved small pox vaccine on 02 Nov 2011, member had initial follow up on 09 Nov 2011. On 11 Nov 2011, member reported to his Corpsman and reported that he had additional spots around the primary vaccine site. Member reported to medical for follow up. Member was instructed to continue treatment of site, ensuring that all additional sites are covered. Member was instructed to allow sites to heal and given additional guidence on methods to reduce spreading. Member is to follow up if symptoms increase or if new symptoms appear.
Age: 15.0
Sex: F
Vaccine: FLUX, HPVX, FLUN3, HPV4
Symptoms: Cellulitis, Erythema, Local swelling, Pruritus
Clinical narrative: Developed local swelling, itching, and redness initially.  Now has associated cellulitis.
Age: 15.0
Sex: F
Vaccine: FLUX, HPVX, FLUN3, HPV4
Symptoms: Injection site cellulitis, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Developed local swelling, itching, and redness initially.  Now has associated cellulitis.
Age: 1.0
Sex: F
Vaccine: FLUX, MMR, PPV, VARCEL
Symptoms: Rash
Clinical narrative: Rash on chest, back and neck.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Hypoaesthesia, Musculoskeletal stiffness, Paraesthesia
Clinical narrative: Tingling, numbness, stiffness in fingers and hands.
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Heart rate increased, Nausea
Clinical narrative: Rapid heart rate, weakness. The following day nausea for three days.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Headache
Clinical narrative: Headache then teeth chattering chills lasting about 2 hrs.  Patient couldn't get warm even with electric mattress pad set at 5 the highest number and additional blankets.
Age: 52.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Pain, Swelling
Clinical narrative: Redness, swelling, pain near injection site.
Age: 23.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Itching, swelling and heat in a 6 inch radius around the injection site lasting for more than a month after injection.
Age: 58.0
Sex: M
Vaccine: FLUX
Symptoms: Biopsy skin abnormal, Leukocytoclastic vasculitis
Clinical narrative: Patient had the influenza vaccine and two days later got leukocytoclastic vasculitis. It has been 8 weeks now and it is resolving. Patient had two trips to the ER and several appointments with doctors.
Age: 16.0
Sex: M
Vaccine: FLU3, HEPA
Symptoms: Hypopnoea, Pallor, Unresponsive to stimuli
Clinical narrative: Pt eyes open non respsonsive, with shallow breathing and pallor. Pt's pulse 47 and BP 90/60.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal pain upper, Arthralgia, Asthenia, Chills, Dizziness
Clinical narrative: Stomach hurting, chills very bad, tingles like fire in feet and hands, urinating frequently joint aching, wheezing, dizziness, weakness.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia, Pollakiuria, Wheezing
Clinical narrative: Stomach hurting, chills very bad, tingles like fire in feet and hands, urinating frequently joint aching, wheezing, dizziness, weakness.
Age: 33.0
Sex: M
Vaccine: TDAP
Symptoms: Chills, Hypoaesthesia, Injection site induration, Injection site pain, Pain in extremity
Clinical narrative: Severe pain at injection site and surrounding muscle tissue. Arm extremely sore and warm to the touch. Arm felt numb and tingly a few times. Ran fever and had chills on 11/11/11. Site still very sore on 11/12/11 and firm to the touch.
Age: 33.0
Sex: M
Vaccine: TDAP
Symptoms: Paraesthesia, Pyrexia, Skin warm
Clinical narrative: Severe pain at injection site and surrounding muscle tissue. Arm extremely sore and warm to the touch. Arm felt numb and tingly a few times. Ran fever and had chills on 11/11/11. Site still very sore on 11/12/11 and firm to the touch.
Age: 62.0
Sex: M
Vaccine: FLUX
Symptoms: Pyrexia, Swelling
Clinical narrative: Swelling & Fever.
Age: 72.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Mobility decreased, Muscular weakness, Pain in extremity
Clinical narrative: Pt's left arm has been painful since 10/27/11 & weak. She has problem lifting her arm up high. She cannot lie on left side because it hurts.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Pyrexia
Clinical narrative: Patient reported she had fever and chills all night after the vaccine. She took some TYLENOL. She did not record the fever, but the TYLENOL helped.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: When contacted patient stated the arm the vaccine was administered in (left) started hurting and was sore. It got progressively worse and pt. had trouble twisting, lifting, and moving her arm. It is still bothersome, but not red, swollen, or require any emergency care. (continues to hurt).
Age: 69.0
Sex: M
Vaccine: FLU3
Symptoms: Pharyngeal oedema
Clinical narrative: Patient came in 3 days after flu shot to let us know he had to go to ER due to his throat swelling after flu shot. ER administered epinephrine and pt was able to go home.
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: A hard red area formed around the site of injection.
Age: 13.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Tenderness
Clinical narrative: 13 yr male got the VARIVAX on the (LA). Has his arm red with no pain only when they touch it hurts.
Age: 16.0
Sex: F
Vaccine: FLU3
Symptoms: Convulsion, Syncope
Clinical narrative: Patient fainted after receiving flu vaccine. She started to seize shortly thereafter. EMS were called to respond. Patient seized for approximately 10 seconds. EMS transported her to hospital for further evaluation.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Rash erythematous
Clinical narrative: Pt. came in on 11-11-11. Pt came in with a red rash on her arm where the subQ injection took place. There was also a slight rash at the site pt said it did not itch. Pt was told to take BENADRYL.
Age: 35.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: Abasia, Asthenia, Hypoaesthesia, Laboratory test, Lumbar puncture
Clinical narrative: Transverse myelitis.
Age: 35.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: Sensory loss
Clinical narrative: Transverse myelitis.
Age: 35.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: Asthenia, Hypoaesthesia, Muscular weakness, Sensory loss
Clinical narrative: Transverse myelitis.
Age: 35.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: Laboratory test, Lumbar puncture, Myelitis transverse, Nuclear magnetic resonance imaging
Clinical narrative: Transverse myelitis.
Age: 67.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Injection site reaction, Mobility decreased, Myalgia
Clinical narrative: Severe pain in upper arm where injection was given.  Pain continues to the present and has resulted in restricted use of my arm.
Age: 67.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Severe pain in upper arm where injection was given.  Pain continues to the present and has resulted in restricted use of my arm.
Age: 21.0
Sex: M
Vaccine: FLU3
Symptoms: Body temperature increased, Malaise
Clinical narrative: Member reported to medical feeling ill, member had temp of 104.3, member was treated with IV fluids, Motrin, and Tylenol. Member received SIQ for 24hrs, will follow up on 14 Nov 2011.
Age: 53.0
Sex: F
Vaccine: FLUN3
Symptoms: Cough, Ear pain, Fatigue, Headache, Myalgia
Clinical narrative: Headache, running nose, cough, extreme tiredness, 11/10/2011 fever, congestion, runny nose, sore throat, cough, tiredness, achy muscles, earache OTC 11/12/2011 fever, congestion, sore throat, tiredness, nausea OTC 11/13/2011 congestion, earache, runny nose and headache, tiredness and slight fever OTC 11/11/2011  OTC - Sinus Headache caps, ThermaFlu, Vicks Vapor Rub
Age: 53.0
Sex: F
Vaccine: FLUN3
Symptoms: Nausea, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: Headache, running nose, cough, extreme tiredness, 11/10/2011 fever, congestion, runny nose, sore throat, cough, tiredness, achy muscles, earache OTC 11/12/2011 fever, congestion, sore throat, tiredness, nausea OTC 11/13/2011 congestion, earache, runny nose and headache, tiredness and slight fever OTC 11/11/2011  OTC - Sinus Headache caps, ThermaFlu, Vicks Vapor Rub
Age: 25.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site reaction, Skin lesion
Clinical narrative: Member reported to medical after 4 satellite lesions appeared around primary site. Reaction was due to large bandage covering wound area, member was instructed on continuing care for sites in the same manner as the primary site. Member was instructed to report to medical if any additional sites appeared or if any new symptoms occur.
Age: 52.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Blood culture, Blood test, Chest X-ray, Chills, Injection site pain
Clinical narrative: Pain at injection site, chills, red rash, very ill feeling and fever.
Age: 52.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Malaise, Pyrexia, Rash erythematous, Ultrasound scan
Clinical narrative: Pain at injection site, chills, red rash, very ill feeling and fever.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Arm is still sore where vaccine was given. Pt tried cool compresses.
Age: 61.0
Sex: M
Vaccine: FLU3, TDAP
Symptoms: Dizziness, Hypertension
Clinical narrative: Dizziness, hypertension (BP 196/99) about 10 min after vaccine administration. Symptoms resolved within 20 min & BP came down to 162/92.
Age: 26.0
Sex: F
Vaccine: FLUX
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain, Pain, X-ray
Clinical narrative: Immediate pain in left shoulder, pain has not subsided. Pain in joint and radiates down arm. Unable to perform functions over my head. Took a double dose of Medrol which helped but once steroid was complete pain returned. Unable to sleep on left shoulder, woken up at night to severe pain. Shoulder aches constantly. Heat, Cold, and Aleve are ineffective. Chiropractic adjustment ineffective in relieving pain. It has been almost 7 weeks and the pain is not subsiding. Tried biofreeze to the area, and also ineffective.
Age: 15.0
Sex: M
Vaccine: HPVX
Symptoms: Antibody test, Antinuclear antibody, CSF virus no organisms observed, Cytomegalovirus test negative, Double stranded DNA antibody
Clinical narrative: Patient is a 15 year old male with acute febrile illness preceding progressive weakness on bilateral upper extremities and bilateral lower extremities likely due to Guillain Barre Syndrome.  Based on EMG findings and physical exam, this is likely an acute on chronic process, as he has evidence of underlying Charcot Marie Tooth.  He received the vaccines 10 days prior to the onset of neurological symptoms and 2 days after an acute viral illness. Pt was treated in the PICU with IVIG for a total treatment course of five days.
Age: 15.0
Sex: M
Vaccine: HPVX
Symptoms: Electromyogram abnormal, Enterovirus test negative, Epstein-Barr virus test negative, Full blood count normal, Guillain-Barre syndrome
Clinical narrative: Patient is a 15 year old male with acute febrile illness preceding progressive weakness on bilateral upper extremities and bilateral lower extremities likely due to Guillain Barre Syndrome.  Based on EMG findings and physical exam, this is likely an acute on chronic process, as he has evidence of underlying Charcot Marie Tooth.  He received the vaccines 10 days prior to the onset of neurological symptoms and 2 days after an acute viral illness. Pt was treated in the PICU with IVIG for a total treatment course of five days.
Age: 15.0
Sex: M
Vaccine: HPVX
Symptoms: Herpes simplex serology negative, Immunoglobulin therapy, Intensive care, Muscular weakness, Neurological symptom
Clinical narrative: Patient is a 15 year old male with acute febrile illness preceding progressive weakness on bilateral upper extremities and bilateral lower extremities likely due to Guillain Barre Syndrome.  Based on EMG findings and physical exam, this is likely an acute on chronic process, as he has evidence of underlying Charcot Marie Tooth.  He received the vaccines 10 days prior to the onset of neurological symptoms and 2 days after an acute viral illness. Pt was treated in the PICU with IVIG for a total treatment course of five days.
Age: 15.0
Sex: M
Vaccine: HPVX
Symptoms: Pyrexia, Red blood cell sedimentation rate normal, Varicella virus test, West Nile virus test negative
Clinical narrative: Patient is a 15 year old male with acute febrile illness preceding progressive weakness on bilateral upper extremities and bilateral lower extremities likely due to Guillain Barre Syndrome.  Based on EMG findings and physical exam, this is likely an acute on chronic process, as he has evidence of underlying Charcot Marie Tooth.  He received the vaccines 10 days prior to the onset of neurological symptoms and 2 days after an acute viral illness. Pt was treated in the PICU with IVIG for a total treatment course of five days.
Age: 68.0
Sex: M
Vaccine: FLU3
Symptoms: Musculoskeletal stiffness
Clinical narrative: Patient states that both his hands got stiff for about 3 days.
Age: 53.0
Sex: F
Vaccine: FLUX
Symptoms: Cough, Dizziness, Headache, Immediate post-injection reaction
Clinical narrative: Deep dry hacking cough that lasted for over a month.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Herpes zoster multi-dermatomal
Clinical narrative: Shingles: Multi-dermatome Lumbar. Treated with acyclovir and steroids.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Cough, Epistaxis, Rhinorrhoea, Sneezing
Clinical narrative: Bloody nose, sneezing, coughing, nasal drainage and joint aches....still persistent 11/13/2011.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash erythematous, Rash pruritic, Swelling
Clinical narrative: Around 6 hours after injection of ZOSTAVAX pt developed red raised itchy patches, swelling all over body. She was taken to ER and given a steroid shot, BENADRYL & MEDROL Rx. Pt called next day - rash resolving.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Blood pressure increased, Nausea, Pharyngeal oedema, Vomiting
Clinical narrative: Throat swelling, nausea & vomiting, increase in blood pressure.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Persistent sore painful arm after vaccination.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site inflammation
Clinical narrative: Pt had inflammation at sight. Pt (retired Nurse) says ZOSTAVAX administered more IM than subq. She came in and showed me and injection site was more 2 side of arm than back.
Age: 0.8
Sex: F
Vaccine: FLU3, HEP
Symptoms: Atelectasis, Chest X-ray abnormal, Dehydration, Febrile convulsion, Full blood count normal
Clinical narrative: This case was received on 27 January 2011 via a third party query tool search on the VAERS database, under reference number 398364. A female infant, age reported as 0.8 (date of birth not reported) had received on 07 September 2010 a left leg (dose 0) of FLUZONE (lot number UT3566BA), and a left leg (dose 2) of RECOMBIVAX-HB (lot number 1484Y) and within 12 hours the patient had a febrile convulsion requiring emergency visit. Laboratory data included a CBC, UA that was within normal limits, and a chest X-ray that revealed (R) upper lobe pneumonia versus atelectasis. Other symptoms coded by VAERS included dehydration, gaze palsy, hypotonia, mental status changes, otitis media acute, pneumonitis, proteinuria, unresponsive to stimuli, and vomiting. Other medications the patient was taking were reported as PREVACID and ZANTAC. The patient had a history of laryngomalacia and GERD. The patient recovered. Documents held by sender: None.
Age: 0.8
Sex: F
Vaccine: FLU3, HEP
Symptoms: Gaze palsy, Hypotonia, Lobar pneumonia, Lymphocyte percentage decreased, Mental status changes
Clinical narrative: This case was received on 27 January 2011 via a third party query tool search on the VAERS database, under reference number 398364. A female infant, age reported as 0.8 (date of birth not reported) had received on 07 September 2010 a left leg (dose 0) of FLUZONE (lot number UT3566BA), and a left leg (dose 2) of RECOMBIVAX-HB (lot number 1484Y) and within 12 hours the patient had a febrile convulsion requiring emergency visit. Laboratory data included a CBC, UA that was within normal limits, and a chest X-ray that revealed (R) upper lobe pneumonia versus atelectasis. Other symptoms coded by VAERS included dehydration, gaze palsy, hypotonia, mental status changes, otitis media acute, pneumonitis, proteinuria, unresponsive to stimuli, and vomiting. Other medications the patient was taking were reported as PREVACID and ZANTAC. The patient had a history of laryngomalacia and GERD. The patient recovered. Documents held by sender: None.
Age: 0.8
Sex: F
Vaccine: FLU3, HEP
Symptoms: Monocyte percentage increased, Neutrophil percentage increased, Otitis media acute, Pneumonia, Pneumonitis
Clinical narrative: This case was received on 27 January 2011 via a third party query tool search on the VAERS database, under reference number 398364. A female infant, age reported as 0.8 (date of birth not reported) had received on 07 September 2010 a left leg (dose 0) of FLUZONE (lot number UT3566BA), and a left leg (dose 2) of RECOMBIVAX-HB (lot number 1484Y) and within 12 hours the patient had a febrile convulsion requiring emergency visit. Laboratory data included a CBC, UA that was within normal limits, and a chest X-ray that revealed (R) upper lobe pneumonia versus atelectasis. Other symptoms coded by VAERS included dehydration, gaze palsy, hypotonia, mental status changes, otitis media acute, pneumonitis, proteinuria, unresponsive to stimuli, and vomiting. Other medications the patient was taking were reported as PREVACID and ZANTAC. The patient had a history of laryngomalacia and GERD. The patient recovered. Documents held by sender: None.
Age: 0.8
Sex: F
Vaccine: FLU3, HEP
Symptoms: Proteinuria, Unresponsive to stimuli, Urine analysis normal, Vomiting
Clinical narrative: This case was received on 27 January 2011 via a third party query tool search on the VAERS database, under reference number 398364. A female infant, age reported as 0.8 (date of birth not reported) had received on 07 September 2010 a left leg (dose 0) of FLUZONE (lot number UT3566BA), and a left leg (dose 2) of RECOMBIVAX-HB (lot number 1484Y) and within 12 hours the patient had a febrile convulsion requiring emergency visit. Laboratory data included a CBC, UA that was within normal limits, and a chest X-ray that revealed (R) upper lobe pneumonia versus atelectasis. Other symptoms coded by VAERS included dehydration, gaze palsy, hypotonia, mental status changes, otitis media acute, pneumonitis, proteinuria, unresponsive to stimuli, and vomiting. Other medications the patient was taking were reported as PREVACID and ZANTAC. The patient had a history of laryngomalacia and GERD. The patient recovered. Documents held by sender: None.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Hypersensitivity, Injection site erythema, Injection site macule, Injection site pruritus
Clinical narrative: Initial report was received on 24 September 2010 from a consumer who is also the patient. An 80 year-old female patient with a past medical history of hypothyroid, MVP, osteoporosis, rebound hyperglycemia and multiple allergies, had received an intramuscular right deltoid injection of FLUZONE HIGH-DOSE, lot number U3603AA on 13 September 2010. On 14 September 2010, the patient had experienced a swollen tongue, swollen lips, blotches on her left arm, small blotches on both her legs and the skin on her right breast was reddened. She also stated she had large red, itchy, warm to the touch and raised like "hives" blotches at the right deltoid in a "three by five area". The patient was examined by an allergist and was recommended corrective treatment of topical Cortisone and oral BENADRYL. No further information was available at the time of this report. The patient's outcome was reported as not recovered. Additional information was received on 24 September 2010 from a consumer who is also the patient. The patient had also reported that they had an "allergic reaction" to a vaccine. No further information was available at the time of this report. The patient's outcome was reported as not recovered. Documents held by sender: none.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site reaction, Injection site warmth, Lip swelling, Rash macular, Rash pruritic
Clinical narrative: Initial report was received on 24 September 2010 from a consumer who is also the patient. An 80 year-old female patient with a past medical history of hypothyroid, MVP, osteoporosis, rebound hyperglycemia and multiple allergies, had received an intramuscular right deltoid injection of FLUZONE HIGH-DOSE, lot number U3603AA on 13 September 2010. On 14 September 2010, the patient had experienced a swollen tongue, swollen lips, blotches on her left arm, small blotches on both her legs and the skin on her right breast was reddened. She also stated she had large red, itchy, warm to the touch and raised like "hives" blotches at the right deltoid in a "three by five area". The patient was examined by an allergist and was recommended corrective treatment of topical Cortisone and oral BENADRYL. No further information was available at the time of this report. The patient's outcome was reported as not recovered. Additional information was received on 24 September 2010 from a consumer who is also the patient. The patient had also reported that they had an "allergic reaction" to a vaccine. No further information was available at the time of this report. The patient's outcome was reported as not recovered. Documents held by sender: none.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Swollen tongue, Urticaria
Clinical narrative: Initial report was received on 24 September 2010 from a consumer who is also the patient. An 80 year-old female patient with a past medical history of hypothyroid, MVP, osteoporosis, rebound hyperglycemia and multiple allergies, had received an intramuscular right deltoid injection of FLUZONE HIGH-DOSE, lot number U3603AA on 13 September 2010. On 14 September 2010, the patient had experienced a swollen tongue, swollen lips, blotches on her left arm, small blotches on both her legs and the skin on her right breast was reddened. She also stated she had large red, itchy, warm to the touch and raised like "hives" blotches at the right deltoid in a "three by five area". The patient was examined by an allergist and was recommended corrective treatment of topical Cortisone and oral BENADRYL. No further information was available at the time of this report. The patient's outcome was reported as not recovered. Additional information was received on 24 September 2010 from a consumer who is also the patient. The patient had also reported that they had an "allergic reaction" to a vaccine. No further information was available at the time of this report. The patient's outcome was reported as not recovered. Documents held by sender: none.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia oral, Throat irritation
Clinical narrative: Initial report received from a Nurse Practitioner on 17 September 2010. A 31-year-old female patient had received a left arm dose of FLUZONE SV (lot number U3652AA) on 17 September 2010 and 2 minutes post-vaccination experienced numbness of the tongue and lips; and her throat felt different. The patient was administered epinephrine and emergency medical team was called for transport to the hospital emergency department. It was not reported whether the patient was hospitalized or not, or if further treatment was required. At the time of vaccination, the patient had no concurrent illnesses; was not using any other medications; and had no known allergies. The patient had received flu vaccines in the past, but it was not reported whether any adverse events were noted with these vaccinations. At the time of this report, the patients recovery status was unknown. Follow-up information was received from a health care professional on 16 November 2010 reported that no other information was available at this time. The outcome remained unknown. Follow-up information was received from the health care professional on 30 November 2010, noting that the case had been reviewed and that no additional information was available. Documents held by sender: None.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Eye discharge, Laboratory test, Nausea, Vomiting
Clinical narrative: Initial report was received from a health care professional on 21 September 2010. A male patient with an unreported past medical history, had received FLUZONE HIGH DOSE, lot number U3617AA (date, route and site of administration not reported) and an unspecified amount of time later, experienced nausea, vomiting and "green discharge from the eyes". The patient was sent to the emergency room (ER) "four hours after vaccine" an was admitted for a 24 hour observation. The reporter stated the patient had "some" laboratory (lab) tests (results not reported). She was not aware if any cultures were taken. The patient was discharged from the hospital (date not reported). No further information was available at the time of this report. The patient's outcome was not reported. Follow-up information was received 04 October 2010 and 25 October 2010 from a health care professional. The patient's date of birth was provided; the patient had been 76 years of age at the time of the event. The reporter confirmed that patient's date of vaccination and the event onset both occurred on 20 September 2010. The patient was hospitalized for two days (reported as one day by the reporter); admitted on 20 September 2010 and discharged on 21 September 2010. The patient had no concurrent illness and he had not received any other vaccines within four weeks of FLUZONE HIGH-DOSE. According to the reporter, the patient recovered (date of recovery was unknown). This patient had been one out of a cluster of five patients (same lot number, same reporter). The other four unidentified patients have been captured in case number 2010-05250. The reporter for this case is the same as for case 2010-05250. Documents held by sender: none.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Allergy test, Blood test, Electrocardiogram, Feeling of body temperature change, Laboratory test
Clinical narrative: Initial report was received from a health care professional on 06 October 2010. A 67 year-old female patient with a past medical history of asthma and diabetes mellitus (DM II), had received an intramuscular left deltoid injection of FLUZONE HIGH-DOSE, lot number U3607AA on 29 September 2010 at 10:00 AM and at 1330 PM (same date), experienced a feeling of "very hot and then cold". She had severe nausea, began gagging and dry heaved for about thirty minutes. The patient was hospitalized for two days (dates not provided). Relevant diagnostic test/laboratory data included "nitro, ASA, O2", blood work, EKG, "tachycardia" and allergy tests. No further information was provided at the time of this report. The patient's outcome was reported as not recovered. Follow-up information received from a pharmacist on 22 October 2010. Per the reporter, the patient had been hospitalized on 09 September 2010 and discharged on 11 September 2010 and was fully recovered as of 13 September 2010 when the patient stopped by the pharmacy. The pharmacist was unaware of diagnosis and treatments the patient received while hospitalized. It is noted these dates are prior to the previously reported onset date of events of 29 September 2010. Additional information has been requested. Follow-up information was received 12 November 2010 from a health care professional. The event date of onset was confirmed to have been 29 September 2010. The patient was hospitalized for four days (also reported as "2 + 1/2 days") from 29 September 2010 until 02 October 2010 (previously reported as from 09 September 2010 and discharged on 11 September 2010). According to the reporter, the patient was fully recovered when they stopped by the pharmacy on 04 October 2010 (previously reported as 13 September 2010). Documents held by sender: none.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Retching, Tachycardia
Clinical narrative: Initial report was received from a health care professional on 06 October 2010. A 67 year-old female patient with a past medical history of asthma and diabetes mellitus (DM II), had received an intramuscular left deltoid injection of FLUZONE HIGH-DOSE, lot number U3607AA on 29 September 2010 at 10:00 AM and at 1330 PM (same date), experienced a feeling of "very hot and then cold". She had severe nausea, began gagging and dry heaved for about thirty minutes. The patient was hospitalized for two days (dates not provided). Relevant diagnostic test/laboratory data included "nitro, ASA, O2", blood work, EKG, "tachycardia" and allergy tests. No further information was provided at the time of this report. The patient's outcome was reported as not recovered. Follow-up information received from a pharmacist on 22 October 2010. Per the reporter, the patient had been hospitalized on 09 September 2010 and discharged on 11 September 2010 and was fully recovered as of 13 September 2010 when the patient stopped by the pharmacy. The pharmacist was unaware of diagnosis and treatments the patient received while hospitalized. It is noted these dates are prior to the previously reported onset date of events of 29 September 2010. Additional information has been requested. Follow-up information was received 12 November 2010 from a health care professional. The event date of onset was confirmed to have been 29 September 2010. The patient was hospitalized for four days (also reported as "2 + 1/2 days") from 29 September 2010 until 02 October 2010 (previously reported as from 09 September 2010 and discharged on 11 September 2010). According to the reporter, the patient was fully recovered when they stopped by the pharmacy on 04 October 2010 (previously reported as 13 September 2010). Documents held by sender: none.
Sex: M
Vaccine: FLU3
Symptoms: Blood bicarbonate decreased, Blood culture negative, Blood glucose increased, Computerised tomogram head, Computerised tomogram normal
Clinical narrative: This case was received on 27 January 2011 via a third party query tool search on the VAERS database, under reference number (VAERS ID 402540). A male patient with a reported age of 1.6 (months or years were not reported), had received a first dose right arm injection of FLUZONE, lot number UT3570DA on 05 October 2010 and one day later on 06 October 2010 experienced a one episode of febrile seizure (104.5). The patient was evaluated in the emergency room, hospitalized and treated with TYLENOL and MOTRIN "after admission". A physical exam revealed an "erythematous throat, no exudates and no vesicles". Diagnostic and laboratory tests included an unremarkable head CT, a negative rapid influenza virus test, a negative UA and urine culture, CBC with increased blood glucose (GLU "18C"), a Chem 20 with decreased blood bicarbonate (16.2 HCO3) and blood cultures showed "no growth to date". No further information was provided at the time of the report. The patient's outcome was reported as recovered. Documents held by sender: none.
Sex: M
Vaccine: FLU3
Symptoms: Culture urine negative, Febrile convulsion, Full blood count abnormal, Influenza virus test negative, Laboratory test abnormal
Clinical narrative: This case was received on 27 January 2011 via a third party query tool search on the VAERS database, under reference number (VAERS ID 402540). A male patient with a reported age of 1.6 (months or years were not reported), had received a first dose right arm injection of FLUZONE, lot number UT3570DA on 05 October 2010 and one day later on 06 October 2010 experienced a one episode of febrile seizure (104.5). The patient was evaluated in the emergency room, hospitalized and treated with TYLENOL and MOTRIN "after admission". A physical exam revealed an "erythematous throat, no exudates and no vesicles". Diagnostic and laboratory tests included an unremarkable head CT, a negative rapid influenza virus test, a negative UA and urine culture, CBC with increased blood glucose (GLU "18C"), a Chem 20 with decreased blood bicarbonate (16.2 HCO3) and blood cultures showed "no growth to date". No further information was provided at the time of the report. The patient's outcome was reported as recovered. Documents held by sender: none.
Sex: M
Vaccine: FLU3
Symptoms: Pharyngeal erythema, Urine analysis normal
Clinical narrative: This case was received on 27 January 2011 via a third party query tool search on the VAERS database, under reference number (VAERS ID 402540). A male patient with a reported age of 1.6 (months or years were not reported), had received a first dose right arm injection of FLUZONE, lot number UT3570DA on 05 October 2010 and one day later on 06 October 2010 experienced a one episode of febrile seizure (104.5). The patient was evaluated in the emergency room, hospitalized and treated with TYLENOL and MOTRIN "after admission". A physical exam revealed an "erythematous throat, no exudates and no vesicles". Diagnostic and laboratory tests included an unremarkable head CT, a negative rapid influenza virus test, a negative UA and urine culture, CBC with increased blood glucose (GLU "18C"), a Chem 20 with decreased blood bicarbonate (16.2 HCO3) and blood cultures showed "no growth to date". No further information was provided at the time of the report. The patient's outcome was reported as recovered. Documents held by sender: none.
Age: 29.0
Sex: M
Vaccine: FLU3
Symptoms: Back pain, Borrelia test negative, General physical health deterioration, Grip strength decreased, Guillain-Barre syndrome
Clinical narrative: Initial report received from a health care professional on 05 October 2010. A male patient, with no medical history provided, received on an unknown date an injection (route and site not provided) of FLUZONE, lot number U3655AA. The patient developed Guillain Barre' Syndrome (GBS) 2-3 days after the administration of FLUZONE. The patient started with back pain and then he lost feeling on the left side of his body and it then moved to the right side of the body. The patient was hospitalized on 28 September (year not provided) and spent over a week in the hospital. The outcome was not reported. Follow-up information was received 14 October 2010 from a health care professional. The patient was 29 years of age and he was vaccinated on 08 September 2010. Two days later, he developed low back pain and leg weakness. One to two days later, he was evaluated and hospitalized for seven days (dates not reported). He received a panel of tests which included a MRI, Lyme serology and a "host of other things"; all with negative findings. The patient continued to be followed by his neurologist as an outpatient; however, his condition progressively worsened "to the point where he was writing at work one day and the pen just fell out of his hand". The patient was subsequently readmitted to the hospital ICU (intensive care unit) on 28 September 2010 (also reported as "this past Tuesday"). Corrective treatments consisted of plasmapheresis without any improvement, however; the patient was able to breathe on his own. According to the reporter, the patient's neurologist thought the patient had GBS caused by the influenza vaccine. No additional information was provided at the time of the report. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: FLU3
Symptoms: Intensive care, Laboratory test normal, Muscular weakness, Nuclear magnetic resonance imaging normal, Plasmapheresis
Clinical narrative: Initial report received from a health care professional on 05 October 2010. A male patient, with no medical history provided, received on an unknown date an injection (route and site not provided) of FLUZONE, lot number U3655AA. The patient developed Guillain Barre' Syndrome (GBS) 2-3 days after the administration of FLUZONE. The patient started with back pain and then he lost feeling on the left side of his body and it then moved to the right side of the body. The patient was hospitalized on 28 September (year not provided) and spent over a week in the hospital. The outcome was not reported. Follow-up information was received 14 October 2010 from a health care professional. The patient was 29 years of age and he was vaccinated on 08 September 2010. Two days later, he developed low back pain and leg weakness. One to two days later, he was evaluated and hospitalized for seven days (dates not reported). He received a panel of tests which included a MRI, Lyme serology and a "host of other things"; all with negative findings. The patient continued to be followed by his neurologist as an outpatient; however, his condition progressively worsened "to the point where he was writing at work one day and the pen just fell out of his hand". The patient was subsequently readmitted to the hospital ICU (intensive care unit) on 28 September 2010 (also reported as "this past Tuesday"). Corrective treatments consisted of plasmapheresis without any improvement, however; the patient was able to breathe on his own. According to the reporter, the patient's neurologist thought the patient had GBS caused by the influenza vaccine. No additional information was provided at the time of the report. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: FLU3
Symptoms: Sensory loss
Clinical narrative: Initial report received from a health care professional on 05 October 2010. A male patient, with no medical history provided, received on an unknown date an injection (route and site not provided) of FLUZONE, lot number U3655AA. The patient developed Guillain Barre' Syndrome (GBS) 2-3 days after the administration of FLUZONE. The patient started with back pain and then he lost feeling on the left side of his body and it then moved to the right side of the body. The patient was hospitalized on 28 September (year not provided) and spent over a week in the hospital. The outcome was not reported. Follow-up information was received 14 October 2010 from a health care professional. The patient was 29 years of age and he was vaccinated on 08 September 2010. Two days later, he developed low back pain and leg weakness. One to two days later, he was evaluated and hospitalized for seven days (dates not reported). He received a panel of tests which included a MRI, Lyme serology and a "host of other things"; all with negative findings. The patient continued to be followed by his neurologist as an outpatient; however, his condition progressively worsened "to the point where he was writing at work one day and the pen just fell out of his hand". The patient was subsequently readmitted to the hospital ICU (intensive care unit) on 28 September 2010 (also reported as "this past Tuesday"). Corrective treatments consisted of plasmapheresis without any improvement, however; the patient was able to breathe on his own. According to the reporter, the patient's neurologist thought the patient had GBS caused by the influenza vaccine. No additional information was provided at the time of the report. Documents held by sender: None.
Age: 90.0
Sex: F
Vaccine: FLU3
Symptoms: Lip swelling, Oedema mouth
Clinical narrative: Initial report was received 07 October 2010 from a health care professional. A 90-year-old female patient had received an intramuscular injection of FLUZONE HIGH-DOSE, lot number U3604BA on 04 October 2010 and two days later, the patient reported she had swollen lips and the inside of her mouth was swollen. She had no concurrent illness at the time of vaccination. Outcome was reported as unknown. No additional information was provided at the time of the report. Follow-up information was received from a health care professional on 29 November 2010. The patient was seen by a private physician and was told the reaction was not due to the FLUZONE vaccine but was due to a medication that the patient was taking. The outcome was reported as recovered. Documents held by sender: None.